Bendamustine salvage for relapsed - refractory multiple myeloma: a retrospective analysis of outcomes in heavily pretreated patients

被引:0
|
作者
Singh, Aakanksha [1 ]
Agrawal, Narendra [1 ]
Haldar, Rohan [1 ]
Bhurani, Dinesh [1 ]
Raychoudhari, Jyoti Shankar [1 ]
机构
[1] Rajiv Gandhi Canc Inst & Res Ctr, New Delhi, India
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-314
引用
收藏
页码:S211 / S211
页数:1
相关论文
共 50 条
  • [11] Daratumumab monotherapy in heavily pretreated Asians patients with relapsed and refractory multiple myeloma
    Yoon, Sung-Soo
    Byun, Ja Min
    Park, Hyunkyung
    Lee, Ji Yun
    Koh, Youngil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E155 - E156
  • [12] Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Weiss, Brendan M.
    Plesner, Torben
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk M.
    Voorhees, Peter M.
    Richardson, Paul G.
    Chari, Ajai
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa M.
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2016, 128 (01) : 37 - 44
  • [13] Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Usmani, Saad
    Weiss, Brendan
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk
    Voorhees, Peter M.
    Richardson, Paul G.
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2015, 126 (23)
  • [14] Metronomic therapy for heavily pretreated relapsed/refractory multiple myeloma (RRMM).
    Papanikolaou, Xenofon
    Szymonifka, Jackie
    Mitchell, Alan
    Keller, Jason
    Heuck, Christoph Johann
    Waheed, Sarah
    Usmani, Saad Zafar
    Nair, Bijay
    Van Rhee, Frits
    Medlin, Stephen Charles
    Bailey, Clyde
    Petty, Nathan
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [15] Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group
    Grzasko, Norbert
    Charlinski, Grzegorz
    Morawska, Marta
    Kicinski, Pawel
    Waszczuk-Gajda, Anna
    Drozd-Sokolowska, Joanna
    Subocz, Edyta
    Blonska, Danuta
    Razny, Malgorzata
    Druzd-Sitek, Agnieszka
    Holojda, Jadwiga
    Swiderska, Alina
    Usnarska-Zubkiewicz, Lidia
    Masternak, Anna
    Giannopoulos, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [16] MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH BENDAMUSTINE
    Cerchione, C.
    Madonna, E.
    Pareto, A. E.
    Marano, L.
    Pugliese, N.
    Peluso, I.
    Seneca, E.
    Cerciello, G.
    Avilia, S.
    Basile, S.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2014, 99 : 650 - 650
  • [17] Outcomes with Panobinostat in Heavily Pretreated Multiple Myeloma Patients
    Pan, Darren
    Mouhieddine, Tarek H.
    Upadhyay, Ranjan
    Casasanta, Nicole
    Lee, Angela
    Zubizarreta, Nicole
    Moshier, Erin
    Richter, Joshua
    BLOOD, 2022, 140 : 12483 - 12484
  • [18] Outcomes with panobinostat in heavily pretreated multiple myeloma patients
    Pan, Darren
    Mouhieddine, Tarek H.
    Upadhyay, Ranjan
    Casasanta, Nicole
    Lee, Angela
    Zubizarreta, Nicole
    Moshier, Erin
    Richter, Joshua
    SEMINARS IN ONCOLOGY, 2023, 50 (1-2) : 40 - 48
  • [19] Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis
    Nikolaou, Andreas
    Ambavane, Apoorva
    Shah, Anshul
    Ma, Wenkang
    Tosh, Jon
    Kapetanakis, Venediktos
    Willson, Jenny
    Wang, Feng
    Hogea, Cosmina
    Gorsh, Boris
    Gutierrez, Ben
    Sapra, Sandhya
    Suvannasankha, Attaya
    Samyshkin, Yevgeniy
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (12) : 1137 - 1145
  • [20] Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Basile, Santina
    Marano, Luana
    Peluso, Ilaria
    Simeone, Luigia
    Vitagliano, Orsola
    Palmieri, Salvatore
    Rocco, Stefano
    Pane, Fabrizio
    Ferrara, Felicetto
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S254 - S255